Cargando…

Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common hereditary kidney diseases that frequently result in renal failure. In this cross-sectional observational cohort study, we evaluated urinary angiotensinogen (AGT) as a potential biomarker to assess renal funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hayne Cho, Kang, Ah-Young, Jang, Joon Young, Kim, Hyunsuk, Han, Miyeun, Oh, Kook-Hwan, Kim, Seung Hyup, Noh, Jung Woo, Cheong, Hae Il, Hwang, Young-Hwan, Ahn, Curie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475321/ https://www.ncbi.nlm.nih.gov/pubmed/26092580 http://dx.doi.org/10.1186/s12882-015-0075-8

Ejemplares similares

Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease
por: Han, Miyeun, et al.
Publicado: (2014)

Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease
por: Park, Hayne Cho, et al.
Publicado: (2020)

Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2015)

Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease
por: Kim, Hyunho, et al.
Publicado: (2019)

Bioelectrical impedance analysis as a nutritional assessment tool in Autosomal Dominant Polycystic Kidney Disease
por: Ryu, Hyunjin, et al.
Publicado: (2019)

Successfully Treated Escherichia coli-Induced Emphysematous Cyst Infection with Combination of Intravenous Antibiotics and Intracystic Antibiotics Irrigation in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2013)

Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease
por: Ryu, Hyunjin, et al.
Publicado: (2017)

Transcatheter Arterial Embolization Therapy for a Massive Polycystic Liver in Autosomal Dominant Polycystic Kidney Disease Patients
por: Park, Hayne Cho, et al.
Publicado: (2009)

Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing
por: Kim, Hyunsuk, et al.
Publicado: (2019)

Author Correction: Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing
por: Kim, Hyunsuk, et al.
Publicado: (2020)

Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study
por: Park, Hayne Cho, et al.
Publicado: (2012)

Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Kim, Yaerim, et al.
Publicado: (2023)

Effect of Hydrocortisone on Angiotensinogen (AGT) Mutation–Causing Autosomal Recessive Renal Tubular Dysgenesis
por: Tseng, Min-Hua, et al.
Publicado: (2021)

Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients
por: Oh, Yun Kyu, et al.
Publicado: (2021)

Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease
por: Choi, Rihwa, et al.
Publicado: (2014)

Xp11.2 translocation renal cell carcinoma in the autosomal dominant polycystic kidney disease patient with preserved renal function
por: Huh, Hyuk, et al.
Publicado: (2017)

Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease
por: Hwang, Jin Ho, et al.
Publicado: (2013)

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression
por: Kim, Hyunsuk, et al.
Publicado: (2022)

Esophageal Artery Pseudoaneurysm and Takayasu Arteritis in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2018)

Multiple Cardiovascular Manifestations in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kang, Young Ran, et al.
Publicado: (2014)

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study
por: Park, Hayne Cho, et al.
Publicado: (2022)

Synergistic Antiproliferative Effects of All-Trans Retinoic Acid and Paclitaxel on Autosomal Dominant Polycystic Kidney Disease Epithelial Cells
por: Nguyen, Que Thanh Thanh, et al.
Publicado: (2021)

Successful Pregnancy in a Patient with Autosomal Dominant Polycystic Kidney Disease on Long-Term Hemodialysis
por: Jung, Ji Hye, et al.
Publicado: (2014)

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period
por: Huh, Hyuk, et al.
Publicado: (2023)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient
por: Shim, Kwang Eon, et al.
Publicado: (2020)

Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease
por: Shin, Jung Hyun, et al.
Publicado: (2023)

Antisense Inhibition of Angiotensinogen With IONIS-AGT-L(Rx): Results of Phase 1 and Phase 2 Studies
por: Morgan, Erin S., et al.
Publicado: (2021)

Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1-Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy
por: Kolovou, Vana, et al.
Publicado: (2015)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy for extremely severe autosomal dominant polycystic kidney disease: Techniques and outcome
por: Han, Jang Hee, et al.
Publicado: (2022)

DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases
por: Takeda, Yoshimichi, et al.
Publicado: (2021)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

Serum uric acid is associated with coronary artery calcification in early chronic kidney disease: a cross-sectional study
por: Han, Miyeun, et al.
Publicado: (2021)

Tetra-ARMS PCR analysis of angiotensinogen AGT T174M (rs4762) genetic polymorphism in diabetic patients: a comprehensive study
por: Akash, Muhammad Sajid Hamid, et al.
Publicado: (2023)

Cyst Ablation Using a Mixture of N-Butyl Cyanoacrylate and Iodized Oil in Patients with Autosomal Dominant Polycystic Kidney Disease: the Long-Term Results
por: Kim, See Hyung, et al.
Publicado: (2009)

Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease
por: Liu, Jin, et al.
Publicado: (2022)

Unilateral renal displacement in an autosomal dominant polycystic kidney disease patient
por: Kim, Jin, et al.
Publicado: (2023)

Polycystin-1 Expression in Fetal, Adult and Autosomal Dominant Polycystic Kidney
por: Chae, Seoung Wan, et al.
Publicado: (2006)

Infected cyst in patients with autosomal dominant polycystic kidney disease: Analysis of computed tomographic and ultrasonographic imaging features
por: Oh, Jiseon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t3l8718fhmmjpjtp5dbssq5465